← Browse by Condition
Medical Condition

sexual dysfunction

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for sexual dysfunction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — sexual dysfunction Clinical Trials

How many clinical trials are currently recruiting for sexual dysfunction?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for sexual dysfunction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for sexual dysfunction?
sexual dysfunction research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a sexual dysfunction clinical trial?
Eligibility criteria for sexual dysfunction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
University Hospital, Ghent 3 trials
Indiana University 1 trial
Thomas Advanced Medical LLC 1 trial
University of Southern Denmark 1 trial

Recruiting Clinical Trials

NCT06059586
Recruiting
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
Enrollment
20 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT04684602 Phase 1, Phase 2
Recruiting
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Enrollment
5,000 pts
Location
United States
Sponsor
Thomas Advanced Medical LLC
View Trial →
NCT05883553
Recruiting
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
Enrollment
40 pts
Location
Belgium, Netherlands
Sponsor
University Hospital, Ghent
View Trial →
NCT07104292
Recruiting
Pelvic Floor Muscle Training During Pregnancy
Enrollment
734 pts
Location
Denmark
Sponsor
University of Southern Denmark
View Trial →
NCT06639776
Recruiting
Sexual Functioning After Erection Prosthesis Placement in Post Phalloplasty Transgender Persons
Enrollment
150 pts
Location
Belgium
Sponsor
University Hospital, Ghent
View Trial →
NCT06639763
Recruiting
Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients
Enrollment
1,000 pts
Location
Belgium
Sponsor
University Hospital, Ghent
View Trial →

Related Conditions

transgenderism (3) erectile dysfunction (3) gender dysphoria (3) prosthesis durability (2) dyspareunia (1) pelvic pain (1) radiation toxicity (1) autoimmune diseases (1) cardiovascular disorders (1) diabetes complications (1) integumentary disease (1) musculoskeletal disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology